Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1226608311 | 12266083 | 11 | F | 20160329 | 20160808 | 20160413 | 20160811 | PER | US-TAKEDA-2016MPI002856 | TAKEDA | 77.43 | YR | M | Y | 68.00000 | KG | 20160811 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1226608311 | 12266083 | 1 | PS | VELCADE | BORTEZOMIB | 1 | Intravenous (not otherwise specified) | 2.4 MG, 2/WEEK | 222507 | 21602 | 2.4 | MG | INJECTION | BIW | |||||
| 1226608311 | 12266083 | 2 | SS | VELCADE | BORTEZOMIB | 1 | Intravenous (not otherwise specified) | 2.3 MG, UNK | 222507 | 21602 | 2.3 | MG | INJECTION | ||||||
| 1226608311 | 12266083 | 3 | SS | VELCADE | BORTEZOMIB | 1 | Intravenous (not otherwise specified) | 2.3 MG, UNK | 222507 | 21602 | 2.3 | MG | INJECTION | ||||||
| 1226608311 | 12266083 | 4 | SS | PREDNISONE. | PREDNISONE | 1 | Oral | 112 MG, QD | 0 | 112 | MG | TABLET | QD | ||||||
| 1226608311 | 12266083 | 5 | SS | PREDNISONE. | PREDNISONE | 1 | Oral | 100 MG, UNK | 0 | 100 | MG | TABLET | |||||||
| 1226608311 | 12266083 | 6 | SS | PREDNISONE. | PREDNISONE | 1 | Oral | 100 MG, UNK | 0 | 100 | MG | TABLET | |||||||
| 1226608311 | 12266083 | 7 | SS | MELPHALAN | MELPHALAN | 1 | Oral | 16 MG, QD | 1424 | MG | 0 | 16 | MG | QD | |||||
| 1226608311 | 12266083 | 8 | SS | MELPHALAN | MELPHALAN | 1 | Oral | 16 MG, UNK | 1424 | MG | 0 | 16 | MG | ||||||
| 1226608311 | 12266083 | 9 | C | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | Oral | 60 MG, UNK | 0 | 60 | MG | TABLET | |||||||
| 1226608311 | 12266083 | 10 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | Intramuscular | 1000 ?G, UNK | 0 | 1000 | UG | ORAL LIQUID | |||||||
| 1226608311 | 12266083 | 11 | C | LISINOPRIL. | LISINOPRIL | 1 | Oral | 10 MG, UNK | 0 | 10 | MG | TABLET | |||||||
| 1226608311 | 12266083 | 12 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | 5 MG, UNK | 0 | 5 | MG | TABLET | |||||||
| 1226608311 | 12266083 | 13 | C | COLACE | DOCUSATE SODIUM | 1 | Oral | UNK | 0 | TABLET | |||||||||
| 1226608311 | 12266083 | 14 | C | OXYCODONE | OXYCODONE | 1 | Oral | 5 MG, UNK | 0 | 5 | MG | TABLET | |||||||
| 1226608311 | 12266083 | 15 | C | OXYCONTIN | OXYCODONE HYDROCHLORIDE | 1 | Oral | 10 MG, BID | 520 | MG | 0 | 10 | MG | TABLET | BID | ||||
| 1226608311 | 12266083 | 16 | C | OXYCONTIN | OXYCODONE HYDROCHLORIDE | 1 | Oral | 20 MG, BID | 520 | MG | 0 | 20 | MG | TABLET | BID | ||||
| 1226608311 | 12266083 | 17 | C | OXYCONTIN | OXYCODONE HYDROCHLORIDE | 1 | Oral | 30 MG, BID | 520 | MG | 0 | 30 | MG | TABLET | BID | ||||
| 1226608311 | 12266083 | 18 | C | OXYCONTIN | OXYCODONE HYDROCHLORIDE | 1 | Oral | 10 MG, BID | 520 | MG | 0 | 10 | MG | TABLET | BID | ||||
| 1226608311 | 12266083 | 19 | C | MILK OF MAGNESIA | MAGNESIUM HYDROXIDE | 1 | Oral | UNK | 0 | ORAL LIQUID | |||||||||
| 1226608311 | 12266083 | 20 | C | CELEXA | CITALOPRAM HYDROBROMIDE | 1 | Oral | 20 MG, UNK | 0 | 20 | MG | TABLET | |||||||
| 1226608311 | 12266083 | 21 | C | VALTREX | VALACYCLOVIR HYDROCHLORIDE | 1 | Oral | 500 MG, UNK | 0 | 500 | MG | TABLET | |||||||
| 1226608311 | 12266083 | 22 | C | REMERON | MIRTAZAPINE | 1 | Oral | 30 MG, UNK | 0 | 30 | MG | TABLET | |||||||
| 1226608311 | 12266083 | 23 | C | CIPRO | CIPROFLOXACIN HYDROCHLORIDE | 1 | Oral | 500 MG, BID | 0 | 500 | MG | BID | |||||||
| 1226608311 | 12266083 | 24 | C | LEVAQUIN | LEVOFLOXACIN | 1 | Oral | 500 MG, UNK | 0 | 500 | MG | ||||||||
| 1226608311 | 12266083 | 25 | C | FLOMAX | TAMSULOSIN HYDROCHLORIDE | 1 | Oral | 0.4 MG, UNK | 0 | .4 | MG | ||||||||
| 1226608311 | 12266083 | 26 | C | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | 250 ?G, BID | 0 | 250 | UG | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 1226608311 | 12266083 | 1 | Plasma cell myeloma |
| 1226608311 | 12266083 | 4 | Plasma cell myeloma |
| 1226608311 | 12266083 | 7 | Plasma cell myeloma |
| 1226608311 | 12266083 | 9 | Depression |
| 1226608311 | 12266083 | 10 | Vitamin B12 deficiency |
| 1226608311 | 12266083 | 11 | Hypertension |
| 1226608311 | 12266083 | 12 | Hypertension |
| 1226608311 | 12266083 | 13 | Constipation |
| 1226608311 | 12266083 | 14 | Back pain |
| 1226608311 | 12266083 | 15 | Back pain |
| 1226608311 | 12266083 | 19 | Constipation |
| 1226608311 | 12266083 | 20 | Depression |
| 1226608311 | 12266083 | 21 | Antiviral prophylaxis |
| 1226608311 | 12266083 | 22 | Depression |
| 1226608311 | 12266083 | 23 | Prostatitis |
| 1226608311 | 12266083 | 24 | Prostatitis |
| 1226608311 | 12266083 | 25 | Urinary retention |
| 1226608311 | 12266083 | 26 | Dyspnoea |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 1226608311 | 12266083 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 1226608311 | 12266083 | Dyspnoea | |
| 1226608311 | 12266083 | Febrile neutropenia | |
| 1226608311 | 12266083 | Pancytopenia | |
| 1226608311 | 12266083 | Prostatitis | |
| 1226608311 | 12266083 | Tremor | |
| 1226608311 | 12266083 | Urinary retention |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 1226608311 | 12266083 | 1 | 20151228 | 20160328 | 0 | |
| 1226608311 | 12266083 | 2 | 20160516 | 0 | ||
| 1226608311 | 12266083 | 3 | 20160523 | 0 | ||
| 1226608311 | 12266083 | 4 | 20151228 | 0 | ||
| 1226608311 | 12266083 | 5 | 20160322 | 20160325 | 0 | |
| 1226608311 | 12266083 | 6 | 20160516 | 20160519 | 0 | |
| 1226608311 | 12266083 | 7 | 20151228 | 20160325 | 0 | |
| 1226608311 | 12266083 | 8 | 20160516 | 20160519 | 0 | |
| 1226608311 | 12266083 | 9 | 2014 | 0 | ||
| 1226608311 | 12266083 | 10 | 2012 | 0 | ||
| 1226608311 | 12266083 | 11 | 2012 | 0 | ||
| 1226608311 | 12266083 | 12 | 2012 | 0 | ||
| 1226608311 | 12266083 | 13 | 201510 | 0 | ||
| 1226608311 | 12266083 | 14 | 20151130 | 0 | ||
| 1226608311 | 12266083 | 15 | 20151216 | 20151231 | 0 | |
| 1226608311 | 12266083 | 16 | 20151231 | 20160104 | 0 | |
| 1226608311 | 12266083 | 17 | 20160104 | 0 | ||
| 1226608311 | 12266083 | 18 | 20160516 | 0 | ||
| 1226608311 | 12266083 | 19 | 20160104 | 0 | ||
| 1226608311 | 12266083 | 20 | 20160118 | 20160302 | 0 | |
| 1226608311 | 12266083 | 21 | 20151228 | 0 | ||
| 1226608311 | 12266083 | 22 | 20160303 | 20160329 | 0 | |
| 1226608311 | 12266083 | 23 | 20160330 | 20160401 | 0 | |
| 1226608311 | 12266083 | 24 | 20160401 | 20160402 | 0 | |
| 1226608311 | 12266083 | 25 | 20160330 | 0 | ||
| 1226608311 | 12266083 | 26 | 20160414 | 0 |